EyePoint Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
07.05.26
/
50%
€11.30
Target price
07.05.27
€31.47
Performance (%)
10.62%
Price
08:55
?
Summary
This prediction is currently active. The prediction currently has a performance of 10.62%. This prediction currently runs until 07.05.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| EyePoint Pharmaceuticals Inc. | 2.439% | 2.439% |
| iShares Core DAX® | -2.680% | 2.021% |
| iShares Nasdaq 100 | 0.725% | 2.753% |
| iShares Nikkei 225® | -0.725% | 5.698% |
| iShares S&P 500 | 1.166% | 4.063% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
Eyepoint Pharmaceuticals (EYPT) had its price target lowered by Royal Bank Of Canada from $39.00 to $37.00. They now have an "outperform" rating on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.59
06.11.25
06.11.25
€33.89
06.11.26
06.11.26
35.53%
08:55
08:55
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.18
17.06.25
17.06.25
€24.24
17.06.26
17.06.26
40.62%
18.06.26
18.06.26